<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03770091</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY18090019</org_study_id>
    <nct_id>NCT03770091</nct_id>
  </id_info>
  <brief_title>Impact of TheraWorx Foam on Symptom Relief in Thumb Arthritis</brief_title>
  <official_title>Impact of Theraworx Foam on Pain and Motion and Patient-Reported Outcomes in Thumb Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>John Fowler</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thumb carpometacarpal osteoarthritis (CMC OA) affects up to 33% of people over the age of 40,
      which leads to inflammation, pain, and weakness of the CMC joint. Treatment modalities are
      both conservative and surgical with surgical options including osteotomy, bone excision,
      ligament reconstruction, and various prosthetic implants. The conservative treatment options,
      however, are limited to NSAIDs and bracing or steroid injections.

      Advances in topical therapies have the potential to deliver focused treatment to the CMC
      joint. Novel treatment of inflammation can potentially reduce inflammation and pain
      associated with progressing osteoarthritis. Theraworx Relief is an FDA registered foam that
      has theoretical impact on inflammation reduction in human subjects treated with the topical
      foam.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This pilot study seeks to investigate potential benefit in the use of Theraworx Foam in
      patients diagnosed with thumb CMC OA. Patients presenting to the upper extremity orthopedic
      surgery clinic for thumb/hand/wrist pain will be diagnosed by a Board Certified Hand Surgeon
      as per standard protocols. Patients who are recommended to follow a conservative treatment
      modality and are interested in participating in this study will be randomized into treatment
      or control groups. Both groups will undergo symptom assessment, strength testing, and range
      of motion testing prior to starting the standard conservative treatment of bracing. The
      treatment group will use the TheraWorx topical foam and the compression wrap nightly for 2
      weeks for at least 6 hours per night. Control group will use a compression wrap for the same
      time period. Both groups will return at 1 and 2 weeks for repeat strength and range of motion
      testing and symptom assessment.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric Pain Rating Scale</measure>
    <time_frame>2 weeks</time_frame>
    <description>patient rated pain on scale of 0-10 (0 no pain and 10 maximum pain), will compare baseline and 2 week data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disabilities of the Arm, Shoulder, and Hand (DASH) score</measure>
    <time_frame>2 weeks</time_frame>
    <description>patient rated outcome score on scale of 0-100, with 0 being no disability and 100 complete disability, will compare baseline and 2 week data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thumb Range of Motion</measure>
    <time_frame>2 weeks</time_frame>
    <description>This measures range of motion of the thumb in degrees from 0-90 degrees (0 degrees would be no motion and 90 degrees full motion), will compare baseline and 2 week data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Grip Strength</measure>
    <time_frame>2 weeks</time_frame>
    <description>This measures grip strength in pounds (0 is no grip strength 150 is maximum grip strength), will compare baseline and 2 week data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pinch Strength</measure>
    <time_frame>2 weeks</time_frame>
    <description>This measures pinch strength in pounds (0 is no pinch strength and 20 is maximum pinch strength), will compare baseline and 2 week data</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Arthritis</condition>
  <arm_group>
    <arm_group_label>Foam and Compression Wrap</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will use Theraworx foam and a compression wrap</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Foam and Compression Wrap</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will use placebo foam and a compression wrap</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Foam alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will use Theraworx foam without compression wrap</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Theraworx</intervention_name>
    <description>Theraworx foam applied to skin and/or compression wrap</description>
    <arm_group_label>Foam alone</arm_group_label>
    <arm_group_label>Foam and Compression Wrap</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo foam</description>
    <arm_group_label>Placebo Foam and Compression Wrap</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Thumb CMC arthritis

          2. greater than or equal to age 18

          3. Interested in non-operative treatment of thumb arthritis

        Exclusion Criteria:

          1. Recent corticosteroid injection into the thumb joint

          2. Non-English speaking

          3. skin lesions or rashes on the thumb

          4. current use of topical anti-inflammatory medications

          5. concomitant thumb/wrist diagnoses that would impact the results (as determined by the
             PI)

          6. known allergy to magnesium
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John R Fowler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univ. of Pittsburgh Orthopaedic Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kaufmann Building</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>December 6, 2018</study_first_submitted>
  <study_first_submitted_qc>December 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2018</study_first_posted>
  <last_update_submitted>March 12, 2020</last_update_submitted>
  <last_update_submitted_qc>March 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>John Fowler</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Allantoin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

